Clinical Trial Update: Peri-gravidic Exposure to Endocrine Disrupting Persistent Organic Pollutants

View source ↗

Summary

A completed clinical trial evaluating peri-gravidic exposure to endocrine-disrupting persistent organic pollutants in individuals with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Breast Neoplasm Female | Status: COMPLETED